These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 1371297)

  • 21. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
    Lemoli RM; Fortuna A; Fogli M; Gherlinzoni F; Rosti G; Catani L; Gozzetti A; Miggiano MC; Tura S
    Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use and toxicity of the colony-stimulating factors.
    Schriber JR; Negrin RS
    Drug Saf; 1993 Jun; 8(6):457-68. PubMed ID: 7687134
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Allogeneic marrow transplantation and the use of hematopoietic growth factors.
    Appelbaum FR
    Stem Cells; 1995 Jul; 13(4):344-50. PubMed ID: 7549892
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Current and future use of hemopoietic growth factors].
    Reguart N; Gascón P
    Med Clin (Barc); 2001 Mar; 116(10):390-4. PubMed ID: 11333675
    [No Abstract]   [Full Text] [Related]  

  • 25. Interleukin-3 followed by GM-CSF for delayed engraftment after autologous bone marrow transplantation.
    Crump M; Couture F; Kovacs M; Saragosa R; McCrae J; Brandwein J; Huebsch L; Beauregard-Zollinger L; Keating A
    Exp Hematol; 1993 Mar; 21(3):405-410. PubMed ID: 8440338
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hematopoietic growth factors: overview and clinical applications, Part III.
    Robinson BE; Quesenberry PJ
    Am J Med Sci; 1990 Nov; 300(5):311-21. PubMed ID: 1700606
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Hematopoietic tissue growth factors: clinical factors].
    Polli EE; Foa P
    Ann Ital Med Int; 1991; 6(1 Pt 1):69-81. PubMed ID: 1716450
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hematopoietic growth factors in the treatment of the myelodysplastic syndromes.
    Ganser A
    Curr Opin Hematol; 1995 May; 2(3):204-9. PubMed ID: 9371996
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical use of growth factors in the myelodysplastic syndromes.
    Stein RS
    Am J Med Sci; 1994 May; 307(5):360-7. PubMed ID: 7513498
    [No Abstract]   [Full Text] [Related]  

  • 30. Very low doses of GM-CSF administered alone or with erythropoietin in aplastic anemia.
    Kurzrock R; Talpaz M; Gutterman JU
    Am J Med; 1992 Jul; 93(1):41-8. PubMed ID: 1626572
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The current status of myeloid growth factor therapy.
    Galvani DW
    J R Coll Physicians Lond; 1991 Jul; 25(3):213-7. PubMed ID: 1717684
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hematopoietic growth factors as adjuncts to antiretroviral therapy.
    Miles SA
    AIDS Res Hum Retroviruses; 1992 Jun; 8(6):1073-80. PubMed ID: 1380256
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of cytokines following bone marrow transplantation: indications and controversies.
    Weinthal JA
    Bone Marrow Transplant; 1996 Dec; 18 Suppl 3():S10-4. PubMed ID: 8971400
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hematopoietic growth factors.
    DeLaPena L; Woolery-Antill M; Tomaszewski JG; Gantz S; Bernato DL; DiLorenzo K; Molenda J; Kryk JA
    Cancer Nurs; 1996 Apr; 19(2):135-50. PubMed ID: 8635167
    [No Abstract]   [Full Text] [Related]  

  • 35. A European perspective on haematopoietic growth factors in haemato-oncology: report of an expert meeting of the EORTC.
    Croockewit AJ; Bronchud MH; Aapro MS; Bargetzi MJ; Crown J; Gratwohl A; Lange W; Ludwig H; Martinelli G; Mertelsmann R; Nuessler V; Willemze R; De Witte TJ; Zittoun R; Zwierzina H
    Eur J Cancer; 1997 Oct; 33(11):1732-46. PubMed ID: 9470826
    [No Abstract]   [Full Text] [Related]  

  • 36. The application of hematopoietic growth factors in drug-induced agranulocytosis: a review of 70 cases.
    Sprikkelman A; de Wolf JT; Vellenga E
    Leukemia; 1994 Dec; 8(12):2031-6. PubMed ID: 7528854
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical uses of hematopoietic growth hormones in HIV-related illnesses.
    Mitsuyasu RT
    AIDS Clin Rev; 1993-1994; ():189-212. PubMed ID: 7692940
    [No Abstract]   [Full Text] [Related]  

  • 38. Cytokine use in the management of HIV disease.
    Scadden DT
    J Acquir Immune Defic Syndr Hum Retrovirol; 1997; 16 Suppl 1():S23-9. PubMed ID: 9389312
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical applications of hematopoietic growth factors.
    Vose JM; Armitage JO
    J Clin Oncol; 1995 Apr; 13(4):1023-35. PubMed ID: 7535842
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aspects on the clinical use of hematopoietic growth factors in myelodysplastic syndromes.
    Hast R; Eriksson M; Jakovleva K
    Pol Arch Med Wewn; 1998 Feb; 99(2):144-9. PubMed ID: 9686516
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.